In the Global Bacteriophage Market Research Report published by Emergen Research, key business details are analyzed along with a geographical overview of the Bacteriophage industry, which provides extensive analysis of this sector. This study provides a comprehensive look at the Bacteriophage market from both a qualitative and quantitative perspective as well as crucial statistical information about the market. As of 2024, the research study provides historical data and offers forecasts up to 2032. Furthermore, the report describes emerging and established players of the market, providing an overview of their business, their product portfolio, their strategic alliances, and their plans for expansion.
The global bacteriophage market size was USD 43.52 Million in 2022 and is expected to register a steady revenue CAGR of 4.2% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of antibiotic-resistant bacteria and rising demand for personalized medicine and investments and research activities for the production of bacteriophage based treatments and medications are key factors driving market revenue growth.
Bacteriophages have been shown to be a powerful alternative to antibiotics, which are losing efficacy due to rapid growth and spread of resistance-forming genes. Topically, phage therapy has been utilized to treat secondary infected burn-mediated ulcers, infected diabetic foot ulcers, and other unexplained persistently infected wounds. Recent breakthroughs in phage genetic engineering enable the intentional modification of wild phage isolates to make them more suitable for therapeutic reasons by changing host specificity and/or increasing other traits on demand. Phage synthesis processes have evolved dramatically in the previous five years. In addition, increasing prevalence of antibiotic-resistant microorganisms is another key factor driving revenue growth of the market.
In the Global Bacteriophage Market Research Report published by Emergen Research, key business details are analyzed along with a geographical overview of the Bacteriophage industry, which provides extensive analysis of this sector. This study provides a comprehensive look at the Bacteriophage market from both a qualitative and quantitative perspective as well as crucial statistical information about the market. As of 2024, the research study provides historical data and offers forecasts up to 2032. Furthermore, the report describes emerging and established players of the market, providing an overview of their business, their product portfolio, their strategic alliances, and their plans for expansion.
The global bacteriophage market size was USD 43.52 Million in 2022 and is expected to register a steady revenue CAGR of 4.2% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of antibiotic-resistant bacteria and rising demand for personalized medicine and investments and research activities for the production of bacteriophage based treatments and medications are key factors driving market revenue growth.
Bacteriophages have been shown to be a powerful alternative to antibiotics, which are losing efficacy due to rapid growth and spread of resistance-forming genes. Topically, phage therapy has been utilized to treat secondary infected burn-mediated ulcers, infected diabetic foot ulcers, and other unexplained persistently infected wounds. Recent breakthroughs in phage genetic engineering enable the intentional modification of wild phage isolates to make them more suitable for therapeutic reasons by changing host specificity and/or increasing other traits on demand. Phage synthesis processes have evolved dramatically in the previous five years. In addition, increasing prevalence of antibiotic-resistant microorganisms is another key factor driving revenue growth of the market.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/2245